Tag: 3BL

Originally published on PSEG Newsroom

NEWARK, N.J., October 13, 2026 /3BL/– Newark, NJ – PSEG recently released its 2026 Sustainability Report, providing a comprehensive overview of our impact on customers and communities, and actions PSEG is taking to strengthen operations, enhance transparency and advance environmental stewardship.

The report highlights PSEG’s results and continued progress in areas including energy infrastructure investment, biodiversity, workforce development and philanthropic giving in the communities we serve. It also details how PSEG is helping residential, commercial and industrial customers manage their energy usage through energy efficiency programs, which have helped participating customers save an estimated $1 billion annually.

“For more than 120 years, PSEG has been a partner to the communities we serve,” said Ralph LaRossa, chair, president and CEO of PSEG. “A lot has changed during that time, but our responsibility has remained consistent: provide the reliable energy our customers depend on, keep it as affordable as possible and invest wisely for the future.”

LaRossa continued, “We also recognize that as energy needs change and grow, we must prioritize reliability, affordability and sustainability.”

Key highlights featured in the report include:

• 95% reduction in total Scope 1 and Scope 2 operational greenhouse gas emissions from the 2005 baseline
• More than 91% of all waste generated by the utility recycled in 2025
• Ongoing value of PSEG Nuclear generating plants located in Salem County that provide approximately 40% of New Jersey’s total energy and 80% of the state’s carbon-free energy
• $12.8 million in combined corporate and PSEG Foundation giving in 2025 including a $1.5 million Community Relief initiative in December 2025

Beyond environmental stewardship, the 2026 Sustainability Report highlights how PSE&G provides safe, reliable energy customers can count on. In 2025, PSE&G received JD Power’s distinction of Highest in Customer Satisfaction with Residential Electric Service in the East Region among Large Utilities for the fourth consecutive year and ReliabilityOne® awards including the National Award for Outstanding System Resiliency and the MidAtlantic Metropolitan Reliability Award for the 24th straight year.

The report also demonstrates the broader economic impact of investments that keep critical energy infrastructure safe and reliable. In 2025, PSEG conducted $2.4 billion worth of business with New Jersey-based companies, representing 69% of our total spend. Our workforce development initiatives have supported over 11,000 new jobs in the clean energy sector to date.

View the full report here: 2026 Sustainability Report.

###

About PSEG

Public Service Enterprise Group (PSEG) (NYSE: PEG) is a predominantly regulated infrastructure company operating New Jersey’s largest transmission and distribution utility, serving approximately 2.4 million electric and 1.9 million natural gas customers. PSEG also owns an independent fleet of 3,758 MW of carbon-free, baseload nuclear power generating units in NJ and PA. PSEG aims to power a future where people use energy more efficiently, and it’s safer and delivered more reliably than ever. PSEG is a member of the S&P 500 Index and has been named to the Dow Jones Best in Class North America Index for 18 consecutive years. PSEG’s businesses include Public Service Electric and Gas Co. (PSE&G), PSEG Power and PSEG Long Island (https://corporate.pseg.com).

Originally published on CVS Health Company Newsroom

HARTFORD, Conn., October 13, 2026 /3BL/ – Aetna®, a CVS Health® company (NYSE: CVS), announced today that more than 69 percent of its Medicare Advantage (MA) members are in 2027 plans rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). These results position Aetna as one of the highest-performing large, publicly traded Medicare Advantage organizations in the Star Ratings program for the third consecutive year and highlight strong performance across various clinical quality, preventive care and member experience measures.

“For years, Aetna has been a leader in Star Ratings, and this year’s results highlight our distinction in the market,” said Steve Nelson, President of Aetna. “We continue to strengthen our business through an unwavering focus on the fundamentals and disciplined execution, and we are encouraged by our performance in areas like clinical quality and operational excellence. This focus gives us confidence in our ability to achieve our goal of returning to appropriate margins while at the same time driving continuous improvement and delivering even better experiences and outcomes for the members who count on us.

Outstanding clinical quality performance

Our 2027 Star Ratings results demonstrate excellence across several key clinical quality measures.

• Aetna achieved an outstanding score on Plan All-Cause Readmissions (4.77* out of 5 stars), showcasing the strength of our care coordination programs, provider partnerships and focus on helping members successfully transition between care settings. Keeping members out of the hospital is one of the most important indicators of health care quality.
• Our high-performing scores on Care for Older Adults Medication Review (5.00*) and Care for Older Adults Functional Status Assessment (4.03*) demonstrate the support we provide members in managing their health and maintaining their independence.
• Reinforcing our commitment to early detection and preventive care, we earned strong scores on preventive screening measures, including Colorectal Cancer Screening (4.19*) and Breast Cancer Screening (4.07*).

Delivering a high-quality member experience

Aetna also delivered exceptional results on measures related to member experience and the quality of our customer support.

• Low rates of Complaints about the Drug Plan (4.29*) demonstrate members’ confidence in our service and commitment to resolving issues quickly and effectively.
• Strong performance on Customer Service (4.04*), Getting Needed Care (3.89*) and Getting Needed Prescription Drugs (4.07*) further highlight our focus on making health care easier to access and navigate.
• Aetna earned a high score on Rating of Health Care Quality (4.22*), indicating the positive experiences members had with their health care providers and the broader care experience supported by Aetna.

In addition, we demonstrated operational excellence through outstanding performance in service and administrative measures, including Call Center Foreign Language Interpreter and Teletypewriter Availability (4.99*), Reviewing Appeals Decisions (4.08*), Plan Makes Timely Decisions About Appeals (4.01*) and Drug Price Accuracy (4.01*). These results underscore our commitment to providing accurate information, fair processes, timely decisions and accessible support for every member.

Every year, Medicare evaluates plans based on a 5-star rating system. The Star Ratings are posted at Medicare.gov. Visit AetnaMedicare.com to learn more about the 2027 Aetna Medicare plans. Or call 1-844-588-0041 (TTY: 711), 7 days a week, 8 AM to 8 PM. The Medicare Annual Enrollment Period runs from October 15 through December 7, 2026. A licensed agent may answer your call.

NOTE: Information in this release is based on 2027 Star Ratings data published by CMS on October 8, 2026, and MA and MAPD enrollment as of September 2026. Individual plan ratings may vary.

*FOR STAR RATING MEASURE SCORES: All scores are based on a rating scale of five stars.

About CVS Health

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of June 30, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated 37 million people through a broad range of health insurance products and related services. The Company’s integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

About Aetna

Aetna, a CVS Health business, serves an estimated 37 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers’ compensation administrative services and health information technology products and services. Aetna’s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit Aetna.com.

Aetna Medicare is a HMO, PPO plan with a Medicare contract. Our SNPs also have contracts with State Medicaid programs. Enrollment in our plans depends on contract renewal. See Evidence of Coverage for a complete description of plan benefits, exclusions, limitations and conditions of coverage. Plan features and availability may vary by service area.

To send a complaint to Aetna, call the Plan or the number on your member ID card. To send a complaint to Medicare, call 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week. If your complaint involves a broker or agent, be sure to include the name of the person when filing your grievance.

©2026 Aetna Inc.

Media contact

Phil Blando
Phillip.blando@cvshealth.com

Investor contact

Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com

Y0001_9425651a_2027_M

Originally published on preventcancer.org

This post has been sponsored by Bristol Myers Squibb as part of its sponsorship of the 2026 Prevent Cancer Gala. 

Can AI help close care gaps in lung cancer?

Lung cancer remains the leading cause of cancer death in the United States, with the American Cancer Society projecting about 229,000 new diagnoses and 125,000 deaths in 2026 alone. Behind those numbers lies another part of the story: Medically underserved communities, including many rural areas, experience higher mortality rates for lung cancer and are also less likely to undergo routine screening or biomarker testing.

At Bristol Myers Squibb (BMS), we believe artificial intelligence (AI) can help identify and quantify these health care gaps, accelerate individual diagnosis, detect disparities in treatment pathways, predict risk of outcomes and proactively target interventions. Two ongoing collaborations help demonstrate this approach.

Catching cancer earlier

BMS shares the Prevent Cancer Foundation’s goal to increase awareness about the importance of lung cancer screening to enable earlier detection and better outcomes. However, lung cancer nodules can be small and easily overlooked, and they are sometimes found by chance on imaging done for unrelated reasons. Even when a nodule is spotted, more than half of these patients don’t receive proper follow-up care and may never actually see a specialist.

These challenges present an opportunity for improvement that BMS is tackling through our collaboration with Microsoft. Using AI algorithms that are cleared by the U.S. Food and Drug Administration (FDA), and deployed through Microsoft’s extensive Precision Imaging Network, will help radiologists analyze X-ray and CT images to flag hard-to-detect nodules. Then, workflow tracking tools will help ensure patients flagged with nodules are connected to care rather than fall through the cracks. This multi-year collaboration is currently in its first phase, recruiting pilot sites such as rural hospitals and community clinics.

Supporting better treatment decisions after diagnosis

A second opportunity begins after diagnosis. For patients with advanced non-small cell lung cancer (the most common form of lung cancer), selecting the most effective therapy  depends on biomarker testing. These lab analyses identify specific genetic mutations driving a patient’s cancer. But biomarker testing doesn’t always happen as guidelines recommend, in part because lab and electronic health record systems are often disconnected.

Through our collaboration with Tempus AI, BMS implemented the AI-enabled Tempus Next Pathways program across 13 community-based health systems to build a near real-time view of the patient journey, finding out where and why patients were not receiving the right care according to guidelines.

The results were compelling. By providing these insights to clinical teams, guideline-directed biomarker testing rates rose from 73% to 84% across participating sites. The program also helped explain the reasons behind that gap, such as clinical factors like disease progression or transitions to hospice care, or logistical issues like patients relocating out of their previous health system. This information provided better tools to design targeted interventions.

Two projects, one purpose

Together, these two projects present a picture of what AI-enabled, data-driven and access-focused cancer care can look like: identifying cancer earlier through smarter imaging workflows and enabling evidence-based treatment. For BMS, that combination reflects a broader commitment, one shared with organizations like the Prevent Cancer Foundation, to help innovation in cancer care reach every community.

Learn more about Advancing population health – Bristol Myers Squibb

 

YKK Corporation has published “This is YKK 2026,” its latest integrated report, outlining FY2025 progress, performance and priorities across the company’s business and sustainability initiatives.

The report details achievements, ongoing initiatives and future priorities under the YKK Sustainability Vision 2050, which is organized around five themes: Climate Change, Material Resources, Water Resources, Chemical Management and Respect People.

A key FY2025 milestone was the NATULON® zipper series reaching 56% of YKK’s global zipper sales volume. The report also highlights products designed to support garment recycling and repair, as well as a new award encouraging circular design among fashion students.

Koichi Matsushima, President of YKK Corporation, said:

“Since formulating the YKK Sustainability Vision 2050, we have continued to advance initiatives under its five themes. In FY2025, YKK was named to CDP’s Climate Change “A List” for the third consecutive year, and the NATULON® zipper series accounted for more than half of our global zipper sales volume. These results demonstrate progress while underscoring the work ahead, including further reductions in CO2 emissions and expanded use of renewable energy.”

Product Initiatives Toward a Circular Economy

Encouraging Circular Design

Selected FY2025 Sustainability Results

• Climate Change: YKK received the highest “A List” rating in the CDP Climate Change questionnaire for the third consecutive year and was named a CDP Supplier Engagement Leader for the fourth consecutive year.
• Water Resources: Water intake totaled 9.234 million metric tons in FY2025, a 19.4% reduction compared with FY2018. YKK introduced four new water recycling facilities, bringing the total to 19 sites.
• Chemical Management: YKK informed suppliers about the YKK Restricted Substance List (2025 version), conducted compliance surveys covering 1,798 companies and introduced InCheck reports for ZDHC Manufacturing Restricted Substances List compliance assessments at 34 companies.
• Respect People: YKK implemented self-checks at all 48 applicable locations and third-party on-site audits at 21 locations under the YKK Global Criteria of Compliance.
• Nature and Biodiversity: YKK began applying the TNFD LEAP approach to assess its relationship with nature and biodiversity. Using the LEAP approach, YKK is analyzing the connections between its domestic and overseas production sites and nature.

Watch Season 6 Episode 3 – Decarbonizing the Cold Chain: Waste Less, Recover More

How do we keep food fresh while reducing emissions across the global cold chain? Decarbonizing refrigerated transport and storage is both a sustainability challenge and a major opportunity.

The cold chain moves food through farms, warehouses, ships, trucks, stores and homes, often over days or weeks. Because it depends heavily on diesel-powered refrigeration, it is a critical focus area for effective decarbonization strategies. At the same time, growing demand for fresh food makes it even more urgent to find scalable, lower-emission ways to protect products in transport.

Dr. Liz Goodwin, Director of Food Loss and Waste at the World Resources Institute, highlights the scale of the issue: as much as 40% of the world’s food is lost or wasted. She challenges the idea that expanding refrigeration alone is enough to solve the problem. Cold chain growth is only effective when it is supported by market demand, operational expertise and the broader systems needed to sustain it.

Claudio Zanframundo, President of Thermo King EMEA & APAC, shares how digital solutions are helping transform the cold chain. With digital tracking and AI, operators can better monitor conditions, reduce inefficiencies and help protect valuable cargo in real time.

Just as important, the conversation goes beyond technology alone. Meeting decarbonization goals will also require strong service networks, enabling infrastructure, supportive regulation and skilled people who know how to run these systems effectively. That is where digital solutions and operational readiness come together to create long-term impact.

Together, they make the case that the biggest gains are in what the system already holds: the food it loses and the energy it wastes. Recovering those, with the right regulation and the people to run the network, is how the cold chain grows and gets cleaner at the same time.

Key moments

• 01:07: How large is the food waste problem?
• 05:01: Why households are a major source of food waste
• 10:13: Building a sustainable food system takes everyone
• 14:00: The complexity of the food chain
• 18:50: How digital tracking reduces waste
• 20:53: Where AI fits into the cold chain

Featured in this Episode:

Hosts:
Dominique Silva, Marketing Leader EMEA, Trane Technologies
Scott Tew, Vice President Sustainability and Managing Director, Center for Energy Efficiency and Sustainability, Trane Technologies

Guests:
Claudio Zanframundo, President, Thermo King, EMEA & APAC
Dr. Liz Goodwin, Director of Food Loss and Waste, World Resources Institute

Episode Resources

• Trane Technologies 2025 Sustainability Report
• The Global Benefits of Reducing Food Waste- World Resource Institute
• Mitigating Food Loss

About Healthy Spaces

Healthy Spaces, a podcast by Trane Technologies, brings together engineers, innovators and industry leaders for bold conversations at the frontier of sustainable technology.

In Season 6, we zero in on the moment when innovation becomes infrastructure – when breakthroughs move beyond the lab and start transforming industries.

From pioneering AI research and next-generation data center cooling to climate-resilient cities and pathways to decarbonization, each episode explores the innovations at the cutting-edge of sustainable technology.

Designed for leaders, builders and anyone with a stake in the future of sustainable technology, the series offers a front-row seat to the ideas and innovations shaping what comes next.

The challenges are real. The solutions are being built now.

Listen and subscribe to Healthy Spaces on your favorite podcast platforms:

Apple Podcasts 
Spotify 
YouTube 
Amazon Music

Every week, millions of people sit down with their mental health therapy provider, take a deep breath, and try to answer a deceptively simple question: “So, how was your week?”

For many, answering that question feels like trying to reconstruct a faded memory. The intense anxiety felt while sitting in traffic on Tuesday or the sudden wave of overwhelm on Thursday evening has lost its sharp edges by Monday morning. Clients often spend the first 15 minutes of a 50-minute appointment trying to recap past events rather than diving into meaningful healing work.

This disconnect between weekly visits is a major contributor to a quiet crisis in mental healthcare: one in four clients discontinue psychotherapy, most after a single session.

At the same time, the market has been flooded with thousands of standalone consumer wellness apps, with research showing that roughly 89% – 92% of mental health applications are abandoned by clients. The reason is simple: self-guided algorithms can’t replace the trust, empathy and safety of a human therapist.

Why Do Standalone Apps Fail Where Clinician-Guided Tools Succeed?

Unlike standalone apps that ask users to navigate their mental health journeys alone, next-generation platforms are designed to operate directly within existing clinical practices. By keeping the mental healthcare provider at the center of the care journey, technology transforms from a passive self-help tool into an active bridge between sessions.

Exemplifying this shift is ReliefAI Health, a digital health venture created through LG NOVA (the North American Innovation Center for LG Electronics), exemplifies this shift. ReliefAI is built as a digital cognitive behavioral therapy (CBT) platform, for providers and clients.  

The mobile app enables clients to engage with their care plan daily and capture their mental state throughout their week.  This gives providers the ability to understand what is going on with their clients at those crucial times to be better able to assess and support their clients through the therapy process. 

Rather than relying on paper notebooks or delayed memory, clients can use voice-journaling features while emotional experiences are still raw, work with interactive CBT exercises, complete clinical assessments and capture real-time mood patterns on their own schedule.

How Does Between-Session Tracking Turn Passive Time Into Active Care?

When technology integrates seamlessly into a clinic’s electronic health records system, the impact on care continuity is profound.

“We see a crucial opportunity for technology to transform mental healthcare by strengthening the vital relationship between therapists and their clients,” says the head of LG NOVA Sokwoo Rhee, Executive Vice President of Innovation at LG Electronics. “ReliefAI answers that need.”

Instead of starting an appointment with a blank slate, clinicians can review synthesized, objective data beforehand—observing mood trends, completed assessments and key themes from voice entries. Mental health providers begin the session already informed, bypassing routine recaps to focus immediately on deeper therapeutic progress.

Rhee says this continuous model provides several distinct advantages for both clients and providers:

• Keeping clients connected to their therapeutic goals throughout the week can significantly reduce early dropout rates and help individuals stay committed through the critical first month.
• Tracking real-time insights that allow providers to tailor treatment plans dynamically and show clients tangible evidence of their growth over time.
• Remote therapeutic monitoring frameworks give practices structured clinical documentation and continuous engagement capabilities.

What Does a Human-Centered Future for Mental Healthcare Look Like?

As National Depression & Mental Health Screening Month highlights the growing demand for accessible, effective care, the narrative around digital health is evolving. The future of mental healthcare does not belong to standalone algorithms or automated substitutes for human connection, according to Rhee.

Instead, the true breakthrough lies in next-generation platforms giving practitioners the data and visibility they need to do their best work, he says, adding: “By turning the days between sessions into an active, supported part of the healing process, clinician-guided technology can help assure that more people stay in care, build resilience and experience lasting well-being.”

In 2018, then 52-year-old Todd Repass Jr. stood up after a meal and immediately knew something was wrong. It was terrifying. He felt weak, short of breath, and, at times, dizzy. The eventual diagnosis – atrial fibrillation (AFib) – kicked off a nearly seven-year health journey, during which he leaned on his son, a professional in the medical device industry, for guidance.

“You just have no clue what’s happening to you,” Repass recalled. “So, you’re confused, you’re scared.”

Atrial fibrillation, commonly called AFib, is an irregular heart rhythm that occurs when the heart’s upper chambers beat out of rhythm. It impacts more than 10 million U.S. adults and can increase the risk of blood clots, stroke, heart failure, and other heart-related complications.i For Repass, receiving the diagnosis brought a new level of uncertainty as he tried to understand what AFib meant for his health.

Over the next several years, Repass tried medication, cardioversion (a procedure intended to restore a regular heartbeat), and lifestyle changes, including adjustments to his diet and sleep schedule. Despite these efforts, his AFib remained unpredictable and disruptive. During episodes, he often felt weak and short of breath and struggled with everyday activities – even short walks with his four golden retrievers. Some of his AFib episodes would last continuously for weeks or even months at a time.

While cardioversions and medication helped lessen some of the symptoms, his AFib remained elusive. His doctors used in-office electrocardiograms (EKGs) and prescribed externally worn, temporary Holter monitors. These external monitoring solutions were prescribed for short durations, often less than 30 days at a time, and were often not able to record his unpredictable AFib episodes. The uncertainty remained.

“The AFib diagnosis is not necessarily the hardest part,” Repass said. “It’s the day-to-day uncertainty that comes with not knowing how to track what’s happening.”

Determined to better understand and manage his condition, Repass began doing his own research, leaning on his son along the way.

“He was a reassuring best friend all the way through it,” Repass said. “He could talk about a certain technology or point me in the right direction on research for my own reassurance and knowledge.”

After discussing options with his care team, his cardiologist recommended the Medtronic LINQ II™ insertable cardiac monitor (ICM). Placed just under the skin, the small device (about 1/3 the size of a AAA battery) continuously monitors the heart and transmits abnormal heart rhythm information to a patient’s care team.

The outpatient procedure took only a few minutes. Afterward, he downloaded the MyCareLink Heart™ mobile app, which allowed him to record symptoms when he felt dizzy, weak, or out of rhythm.

For the first time, Repass no longer had to hope an episode would occur during a scheduled test. When he felt symptoms, he could record them in the app, and his care team could compare what he felt with the heart rhythm information collected by the device.

For several months, the LINQ II ICM recorded episodes of AFib and other abnormal heart rates, providing his care team with additional information to help inform a more targeted treatment strategy. Doctors recommended Repass would be a strong candidate for a new type of cardiac ablation procedure called pulsed field ablation (PFA) using the Medtronic Sphere-9™ catheter. The all-in-one mapping and dual-energy procedure uses both short electrical pulses and radiofrequency energy to target heart tissue responsible for the abnormal electrical signals that cause AFib.

More than a year after his ablation procedure, Repass is AFib-free, and his LINQ II ICM continues to monitor. Not only does he feel better, but the continued monitoring also provides reassurance that his AFib is under control while giving his care team a 24/7 view of his heart rhythm activity.

Today, he exercises, participates more fully in family activities, and spends plenty of time walking and caring for his golden retrievers. He no longer organizes his entire day around trying to prevent a possible AFib trigger.

Looking back, Repass said having his son by his side helped him navigate the uncertainty that came with AFib. His son encouraged him to learn more, ask questions, and seek out information that could help him have informed conversations with his healthcare team.

For Repass, that experience reinforced the importance of educating yourself about your condition and being an active participant in your care.

“Getting the LINQ II and the ablation were probably the best health decisions I’ve ever made in my life,” Repass said.

To learn more about atrial fibrillation and available treatment options, visit https://www.medtronic.com/en-us/l/patients/conditions/atrial-fibrillation-afib.html.

If you have AFib or are experiencing symptoms of an irregular heart rhythm, talk to your doctor about diagnosis and treatment options.

Important Safety Information

Possible risks associated with the implant of the LINQ™ Family ICMs include, but are not limited to, infection at the surgical site, device migration, erosion of the device through the skin and/or sensitivity to the device material. For important safety information, see: https://www.medtronic.com/us-en/patients/treatments-therapies/insertable-heart-monitors/getting-monitor/important-safety-information.html.

Risks associated with the Sphere-9™ catheter may include bleeding and bruising where the catheter was inserted, cough, shortness of breath, infection, temporary or permanent stroke, severe complications leading to hospitalization or potentially death. For important safety information, see: https://www.medtronic.com/en-us/l/patients/treatments-therapies/catheter-ablation-for-atrial-fibrillation.html#benefits-of-pulsed-field-ablation.

Peru is a key player in the global fishmeal and fish oil industry, and reliable logistics are essential to connecting its products with international markets.

Through its partnership with TASA, one of Peru’s leading fishing companies, DP World helps facilitate the movement of fishmeal and fish oil from Peru to customers around the world. With approximately 75% of TASA’s container shipments handled through DP World, the collaboration demonstrates the importance of integrated logistics solutions in supporting international trade.

By strengthening supply chain efficiency and providing reliable access to global markets, DP World helps TASA enhance the competitiveness of Peruvian products on the world stage.

Transforming trade means connecting Peruvian businesses to global opportunities.

Watch the video to discover how DP World and TASA are working together to move Peru’s exports further.

The Picture Proof of Planting photo contest returns for its third year to celebrate over 1,000 FedEx team members delivering conservation to local communities. We received more than 500 photos this year, which got us down to our 15 finalists. Now, after counting nearly 3,000 votes from 41 countries, it is time to meet the five winning teams and the nonprofits that will be receiving the $5,000 USD grants!

We4All Athens: We4all is an environmental NGO based in Athens, Greece, founded after the devastating 2018 Athens fires. Dedicated to healing the planet, they focus on tree planting, ecosystem restoration, and environmental education. Partnering with communities, schools, and global organizations, We4all empowers people to take climate-positive action. Their mission is simple yet powerful: make Earth a healthier home for all, one tree at a time. Together, they’re planting hope for the future.

Korea Green Foundation: Korea Green Foundation is dedicated to tackling climate change and environmental challenges. As Asia’s Green Hub, it collaborates with governments, businesses, and civil society to promote sustainable practices and protect ecosystems. Through education, advocacy, and innovative projects, the foundation inspires action for a sustainable future. Its mission is to create a healthier planet by fostering environmental awareness, supporting environmental initiatives, and empowering communities to be active stewards of nature.

GreenEarth Heritage Foundation Philippines: GreenEarth Heritage Foundation is a non-profit organization dedicated to reforestation, sustainable farming, and community upliftment in the foothills of the Sierra Madre, Bulacan. Through tree planting, organic agriculture, education, and livelihood programs, it restores degraded lands while empowering local families. The foundation nurtures both the environment and human potential, creating a thriving, self-sustaining community rooted in stewardship, hope, and a shared vision for a better future for generations to come.

All China Environment Federation (ACEF): ACEF is a nationwide non-profit environmental organization established in April 2005 with State Council approval. Operating under the Ministry of Ecology and Environment, ACEF unites government bodies, enterprises, and the public to promote sustainable development. Its initiatives span pollution control, biodiversity conservation, climate action, and public environmental education. By fostering collaboration and advocating green policies, ACEF plays a vital role in advancing China’s ecological protection and low-carbon transformation goals.

We4All Mumbai: We4All Mumbai is a community driven environmental initiative dedicated to creating a healthier city through tree planting, sustainability education, and volunteer engagement. The organization partners with schools, local groups, and corporate teams to restore urban ecosystems and inspire long term environmental responsibility. By empowering citizens to take meaningful action, We4All Mumbai works to combat pollution, increase green cover, and build a more resilient future for the city and its communities.

Note: Award of grants to nonprofits that do not have a U.S. affiliate and are not a registered Canadian charity are subject to final vetting and approval by CAF America.

Click here to learn about FedEx Cares, our global community engagement program.

 

 

NEW YORK and LONDON, October 12, 2026 /3BL/ – AccountAbility is pleased to share a discussion between Mr. Sunil (Sunny) A. Misser, Chief Executive Officer of AccountAbility, and Mr. Vincent A. Forlenza, Chairman of Moody’s Corporation, presented at the Accountability in a Sustainable World Conference during NYC Climate Week 2026.

Revisiting their conversation from 2023, on “The Board of Tomorrow” three years earlier, the two leaders examined how corporate Boards are responding to changes in geopolitics, technology, cybersecurity, macro-economics and artificial intelligence, and what these developments mean for strategy, risk management, and effective oversight.

“The fundamental responsibilities of a Board have not changed, but the risks have changed tremendously. Geopolitics, technology, and cybersecurity are now deeply interconnected, requiring Boards to understand both the individual challenges and how they affect one another.” — Mr. Vincent A. Forlenza, Chairman, Moody’s Corporation

Five Takeaways for “The Board of Tomorrow”

• ‍Geopolitical preparedness is becoming a core Board capability. Political developments have direct economic consequences, affecting investment, supply chains, operating costs, and access to capital. Boards must carefully consider and evaluate these risks when making strategic decisions.‍
• Changing geopolitical and technological realities require Boards and Management to rethink their fundamental strategies, rather than simply adjusting an existing plan. Boards must be prepared to question whether existing business models and strategic priorities remain relevant as external conditions change.‍
• Risk has, once again, moved to the center of the Board agenda. While the fundamentals of governance remain unchanged, Boards must oversee a broader range of risks with greater potential to affect business performance.‍
• AI can help Boards make better-informed decisions. AI can help directors analyze information, identify gaps, and ask more informed questions of management. However, it cannot replace independent judgment or effective oversight.‍
• The intersection of risks causes complex compounding effects. Geopolitical developments, technology, climate, and cybersecurity risks can amplify one another, creating consequences that may not be apparent when each is considered separately.

Mr. Misser underscored how significantly the external environment has shifted since their earlier conversation:

“Geopolitics is Geoeconomics – Geopolitical disruptions have direct and amplified Geoeconomic outcomes. These disruptions affect supply chains, energy costs and availability, employment, inflation, and the cost of capital. Together, these pressures place significant strain on businesses and economies.” — Mr. Sunil (Sunny) A. Misser, Chief Executive Officer, AccountAbility

The conversation offers a timely look at how experienced Board leaders are navigating a governance environment that has changed considerably in just three years, while the core responsibilities of effective oversight remain and continue to grow.

Watch the full conversation here.

About AccountAbility

AccountAbility is an expert international Sustainability Advisory and Standards firm. Established in 1995 and structured as a Public Benefit Corporation, we work with businesses, investors, governments, and multilateral organizations to innovate and lead the global sustainability agenda by improving the practices and performance of organizations. We focus on delivering practical, effective, and enduring results that enable our clients and standards users to succeed.

AccountAbility operates globally from offices in New York, London, Riyadh, and Dubai, supported by a highly qualified team recognized by the Financial Times, Forbes, and Capital Finance International. AccountAbility is also acknowledged in the U.S. Library of Congress as a source of ESG & sustainability research and thought leadership.

*********

For media inquiries or further information, please contact:

Ms. Allison McKay

Allison.mckay@accountability.org
Senior Associate
AccountAbility

Website: www.accountability.org